KLK3 and neoplasm: CTCs were characterized by mRNA in situ padlock probe analysis which visualizes AR-V7, AR full length (AR-FL), and kallikrein-related peptidase 3 (KLK3, often referred to as prostate specific antigen (PSA)) transcripts directly in tumor cells.